Dexamethasone-induced Ras protein 1 negatively regulates protein kinase C delta: implications for adenylyl cyclase 2

Chau H Nguyen1, Val J Watts

  • 1Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 Stadium Mall Drive, RHPH 210, West Lafayette, IN 47907, USA.

Molecular Pharmacology
|February 21, 2006
PubMed

Insights

Dexamethasone-induced Ras protein 1 (Dexras1) negatively regulates protein kinase C (PKC) delta, impacting adenylyl cyclase 2 (AC2) signaling. This Dexras1 interaction with PKC delta is isoprenylation-dependent, modulating AC2 activity.

Area of Science:

  • Cellular signaling and signal transduction pathways.
  • Molecular mechanisms of enzyme regulation.
  • G protein-coupled receptor signaling.

Background:

  • Adenylyl cyclase type 2 (AC2) is a key enzyme in cellular signaling, modulated by various pathways including Gbetagamma and protein kinase C (PKC).
  • Dexamethasone-induced Ras protein 1 (Dexras1) has been implicated in blocking receptor-mediated Gbetagamma signaling.
  • The precise role of Dexras1 in regulating PKC isoforms and their downstream effects on AC2 remains to be fully elucidated.

Purpose of the Study:

  • To identify Dexras1 as a negative regulator of PKC delta.
  • To investigate the functional consequences of Dexras1-PKC delta interaction on AC2 signaling.
  • To determine the mechanism and cellular localization of Dexras1's regulatory action on PKC delta and AC2.

Main Methods:

  • Expression of Dexras1 in human embryonic kidney 293 cells.
  • Assessment of AC2 activity in response to dopamine D2 receptor stimulation and phorbol 12-myristate 13-acetate (PMA).
  • Analysis of PKC delta autophosphorylation and kinase activity using co-immunoprecipitation and [gamma-32P]ATP incorporation.
  • Investigation of the role of isoprenylation using a farnesyltransferase inhibitor (FTI-277) and a CAAX box-deficient mutant (C277S).

Main Results:

  • Dexras1 expression abolished dopamine D2 receptor-mediated potentiation of AC2 activity and reduced PMA-stimulated AC2 activity.
  • Dexras1 specifically interfered with PKC delta autophosphorylation and kinase activity, but not PKC alpha or epsilon.
  • Dexras1 co-immunoprecipitated with PKC delta at the cellular membrane, and this interaction was dependent on Dexras1 isoprenylation.
  • Dexras1 did not affect Galpha(s)-mediated cAMP accumulation or PKC delta membrane translocation.

Conclusions:

  • Dexras1 acts as a negative regulator of PKC delta activity through an isoprenylation-dependent mechanism at the cellular membrane.
  • Dexras1 indirectly modulates AC2 activity by inhibiting both Gbetagamma- and PKC delta-mediated signaling pathways.
  • This study reveals a novel role for Dexras1 in cellular signal transduction by linking Gbetagamma and PKC signaling to AC2 regulation.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...